|
2024 Journal Article Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocolSeib, Kate L., Donovan, Basil, Thng, Caroline, Lewis, David A., McNulty, Anna, Fairley, Christopher K., Yeung, Barbara, Jin, Fengyi, Fraser, Doug, Bavinton, Benjamin R., Law, Matthew, Chen, Marcus Y., Chow, Eric P. F., Whiley, David M., Mackie, Brent, Jennings, Michael P., Jennison, Amy V., Lahra, Monica M. and Grulich, Andrew E. (2024). Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocol. BMJ Open, 14 (4) e081675, 1-9. doi: 10.1136/bmjopen-2023-081675 |
|
2024 Journal Article Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsisChai, Gene G., Tu, Quyen, Cotta, Menino O., Bauer, Michelle J., Balch, Ross, Okafor, Charles, Comans, Tracy, Kruger, Peter, Meyer, Jason, Shekar, Kiran, Brady, Kara, Fourie, Cheryl, Sharp, Natalie, Vlad, Luminita, Whiley, David, Ungerer, Jacobus P. J., McWhinney, Brett C., Farkas, Andras, Paterson, David L., Clark, Julia E., Hajkowicz, Krispin, Raman, Sainath, Bialasiewicz, Seweryn, Lipman, Jeffrey, Forde, Brian M., Harris, Patrick N. A., Schlapbach, Luregn J., Coin, Lachlan, Roberts, Jason A. and Irwin, Adam D. (2024). Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis. Intensive Care Medicine, 50 (4), 539-547. doi: 10.1007/s00134-024-07353-3 |
|
2024 Journal Article High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)Ouk, V, Heng, L Say, Virak, M, Deng, S, Lahra, M M, Frankson, R, Kreisel, K, McDonald, R, Escher, M, Unemo, M, Wi, T, Maatouk, I, Penh, Phnom, Fensham, Vivian, Kersh, Ellen, Cavailler, Philippe, Mundade, Yamuna, Hal, Sebastiaan J van, Kundu, Ratan L, Hogan, Tiffany R, Whiley, David M, Izumi, Kiyohiko, Nishijima, Takeshi, EGASP Cambodia Working Group and Whiley, David (2024). High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP). JAC-Antimicrobial Resistance, 6 (2) dlae053, 2. doi: 10.1093/jacamr/dlae053 |
|
2024 Journal Article Comparison of nasopharyngeal swab vs. lower respiratory tract specimen PCR for the diagnosis of Pneumocystis jirovecii pneumoniaChew, Rusheng, Tozer, Sarah, Ulett, Kimberly, Paterson, David L., Whiley, David, Sloots, Theo, Fielding, David, Zappala, Christopher, Bashirzadeh, Farzad, Hundloe, Justin, Bletchley, Cheryl and Woods, Marion L. (2024). Comparison of nasopharyngeal swab vs. lower respiratory tract specimen PCR for the diagnosis of Pneumocystis jirovecii pneumonia. Open Forum Infectious Diseases, 11 (3) ofae071, ofae071. doi: 10.1093/ofid/ofae071 |
|
2024 Journal Article Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, AustraliaErtl, Nicole G., Anderson, Taylah K., Pardo, Carolyn J., Maidment, Toby I., Murray, Gerald L., Bradshaw, Catriona S., Whiley, David M. and Sweeney, Emma L. (2024). Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia. Journal of Antimicrobial Chemotherapy, 79 (2), 467-469. doi: 10.1093/jac/dkad373 |
|
2024 Journal Article Investigating oral human papillomavirus co-infection with Neisseria gonorrhoeae and Chlamydia trachomatisTrembizki, Ella, Anderson, Taylah, Whiley, David M. and Antonsson, Annika (2024). Investigating oral human papillomavirus co-infection with Neisseria gonorrhoeae and Chlamydia trachomatis. Epidemiology and Infection, 152 e8, e8. doi: 10.1017/s095026882300198x |
|
2024 Journal Article Determining Pneumocystis jirovecii colonisation from infection using PCR-based diagnostics in HIV-negative individualsWatson, Anna Louise, Woodford, John, Britton, Sumudu, Gupta, Rita, Whiley, David and McCarthy, Kate (2024). Determining Pneumocystis jirovecii colonisation from infection using PCR-based diagnostics in HIV-negative individuals. Diagnostics, 14 (1) 114, 114. doi: 10.3390/diagnostics14010114 |
|
2024 Conference Publication Clinical effectiveness, sustainability and quality of a large, decentralised molecular point-of-care testing network for STIs in regional and remote primary care clinics in AustraliaCauser, Louise M., Anderson, David, Andrewartha, Kelly, Armstrong, Paul, Atkinson, David, Badman, Steven, Bastian, Lisa, Carroll, Catherine, Donovan, Basil, Fairley, Christopher, Gunathilake, Manoji, Guy, Rebecca, Hengel, Belinda, Kaldor, John, Leonard, Jessica, Maher, Lisa, Mak, Donna, Moore, Liz, O'Connor, Sean, Persing, David, Rees, Tom, Regan, David, Saha, Amit, Shephard, Mark, Smith, Kirsty, Speers, David, Tangey, Annie, Walshe, Veronica, Wand, Handan ... White, Caitlyn (2024). Clinical effectiveness, sustainability and quality of a large, decentralised molecular point-of-care testing network for STIs in regional and remote primary care clinics in Australia. Annual Meeting of the Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (IDSOG), Boston Ma, Aug 04-06, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2024 Conference Publication Simplifying approaches to detect Mycoplasma genitalium parC resistance mutations, to facilitate individualised fluoroquinolone treatmentSweeney, Emma L., Bradshaw, Catriona, Murray, Gerald, Tickner, Jacob A. and Whiley, David (2024). Simplifying approaches to detect Mycoplasma genitalium parC resistance mutations, to facilitate individualised fluoroquinolone treatment. Annual Meeting of the Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (IDSOG), Boston, MA, United States, 4-6 August 2022. Philadelphia, PA, United States: Lippincott Williams & Wilkins. |
|
2024 Conference Publication gyrA Mutations in Mycoplasma Genitalium Contribute to Moxifloxacin Failure - A New Target For Resistance-guided TherapyMurray, Gerald, Plummer, Erica L., Bodihabadu, Kaveesha, Torres, Jose, Chua, Teck-Phui, Machalek, Dorothy, Garland, Suzanne M., Doyle, Michelle, Sweeney, Emma L., Whiley, David and Bradshaw, Catriona (2024). gyrA Mutations in Mycoplasma Genitalium Contribute to Moxifloxacin Failure - A New Target For Resistance-guided Therapy. Annual Meeting of the Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (IDSOG), Boston, MA, United States, 4-6 August 2022. Philadelphia, PA, United States: Lippincott Williams & Wilkins. |
|
2023 Journal Article Maximizing the Neisseria gonorrhoeae confirmatory rate and the genotypic detection of ciprofloxacin resistance for samples screened with cobas CT/NGPryce, Todd M., Foti, Olivia R., Haygarth, Erin J. and Whiley, David M. (2023). Maximizing the Neisseria gonorrhoeae confirmatory rate and the genotypic detection of ciprofloxacin resistance for samples screened with cobas CT/NG. Journal of Clinical Microbiology, 62 (1) e0103923, 1-14. doi: 10.1128/jcm.01039-23 |
|
2023 Journal Article Evaluation of Illumina® COVIDSeq™ as a Tool for Omicron SARS-CoV-2 CharacterisationLowry, Kym, Bauer, Michelle J., Buckley, Cameron, Wang, Claire, Bordin, Amanda, Badman, Steven, Harris, Patrick N.A., Mackay, Ian and Whiley, David (2023). Evaluation of Illumina® COVIDSeq™ as a Tool for Omicron SARS-CoV-2 Characterisation. Journal of Virological Methods, 322 114827, 1-5. doi: 10.1016/j.jviromet.2023.114827 |
|
2023 Journal Article Rapid inactivation and sample preparation for SARS-CoV-2 PCR-based diagnostics using TNA-Cifer reagent EPollak, Nina, Rawle, Daniel J., Yan, Kexin, Buckley, Cameron, Le, Thuy, Wang, Claire Y., Ertl, Nicole G., Van Huyssteen, Karla, Crkvencic, Nicole, Hashmi, Misha, Lyons, Russell E., Whiley, David M., Suhrbier, Andreas and Macdonald, Joanne (2023). Rapid inactivation and sample preparation for SARS-CoV-2 PCR-based diagnostics using TNA-Cifer reagent E. Frontiers in Microbiology, 14 1238542, 1-12. doi: 10.3389/fmicb.2023.1238542 |
|
2023 Conference Publication Neisseria gonorrhoeae antimicrobial co-resistances: implications for the utility of rapid molecular antimicrobial resistance assays and informing antimicrobial useBell, S. F. E., Ware, R. S., Lewis, D. L., Lahra, M. M. and Whiley, D. W. (2023). Neisseria gonorrhoeae antimicrobial co-resistances: implications for the utility of rapid molecular antimicrobial resistance assays and informing antimicrobial use. Australasian Sexual and Reproductive Health Conference, Sydney, NSW Australia, 18-20 September 2023. |
|
2023 Journal Article Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotypevan Hal, S. J., Whiley, D. M., Le, T., Ray, S., Kundu, R. L., Kerr, E. and Lahra, M. M. (2023). Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype. Journal of Antimicrobial Chemotherapy, 78 (9), 2203-2208. doi: 10.1093/jac/dkad221 |
|
2023 Journal Article Application of the ViroKey® SQ FLEX assay for detection of cytomegalovirus antiviral resistanceHume, Jocelyn, Lowry, Kym, Whiley, David M., Irwin, Adam D., Bletchly, Cheryl and Sweeney, Emma L. (2023). Application of the ViroKey® SQ FLEX assay for detection of cytomegalovirus antiviral resistance. Journal of Clinical Virology, 167 105556, 1-8. doi: 10.1016/j.jcv.2023.105556 |
|
2023 Journal Article gyrA mutations in Mycoplasma genitalium and their contribution to moxifloxacin failure: time for the next generation of resistance-guided therapyMurray, Gerald L, Plummer, Erica L, Bodiyabadu, Kaveesha, Vodstrcil, Lenka A, Huaman, Jose L, Danielewski, Jennifer A, Chua, Teck Phui, Machalek, Dorothy A, Garland, Suzanne, Doyle, Michelle, Sweeney, Emma L, Whiley, David M and Bradshaw, Catriona S (2023). gyrA mutations in Mycoplasma genitalium and their contribution to moxifloxacin failure: time for the next generation of resistance-guided therapy. Clinical Infectious Diseases, 76 (12), 2187-2195. doi: 10.1093/cid/ciad057 |
|
2023 Journal Article A universal reagent for detection of emerging diseases using bioengineered multifunctional yeast nanofragmentsLi, Junrong, Howard, Christopher B., Dey, Shuvashis, Lowry, Kym, Whiley, David M., Puttick, Simon, Rose, Stephen, Lobb, Richard J., Wuethrich, Alain, Edwardraja, Selvakumar and Trau, Matt (2023). A universal reagent for detection of emerging diseases using bioengineered multifunctional yeast nanofragments. Nature Nanotechnology, 18 (10), 1222-1229. doi: 10.1038/s41565-023-01415-1 |
|
2023 Journal Article Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxisWhiley, David M., Tickner, Jacob A., Kundu, Ratan L., Hogan, Tiffany R., van Hal, Sebastiaan J. and Lahra, Monica M. (2023). Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxis. The Lancet Infectious Diseases, 23 (8), e268-e269. doi: 10.1016/s1473-3099(23)00359-6 |
|
2023 Journal Article Antimicrobial susceptibility assays for Neisseria gonorrhoeae: a proof-of-principle population-based retrospective analysisBell, Sara F. E., Ware, Robert S., Lewis, David A., Lahra, Monica M. and Whiley, David M. (2023). Antimicrobial susceptibility assays for Neisseria gonorrhoeae: a proof-of-principle population-based retrospective analysis. The Lancet Microbe, 4 (7), e544-e551. doi: 10.1016/s2666-5247(23)00071-x |
